CeriBell, Inc. (CBLL): Short-Term Debt to Equity Ratio
This CeriBell, Inc. (CBLL) trading chart shows a metric at 0.00. Business revenues are growing through the sale of consumables, gradually capturing the hospital sector. The brand's high status in emergency therapy is confirmed by the success of its cloud-based EEG monitoring. The application of artificial intelligence in brain activity diagnostics minimizes operational risks, enabling the rapid detection of occult seizures.
Analytical breakdowns for CeriBell, Inc.
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
General company analysis:CeriBell, Inc.
Scaling cloud AI platforms for EEG monitoring in hospitals creates significant operational leverage for CeriBell, Inc. (CBLL). This indicator compares obligations due within one year to the market value of equity, assessing refinancing risks during cycle shifts. By analyzing the historical ratio of short-term loans to equity, an investor can discern the balance between financial stability and borrowing efficiency. Low debt leverage confirms price strength amid business expansion.
Analysis of competing companies
Biogen Corp - Short-Term Debt to Capital|Current Liabilities to Capital Neurocrine Corp NBIX|Short-Term Debt to Equity Ratio RGC (Regencell Bioscience)|axsome.com - Short-Term Debt to Capital|Short-Term Debt to Equity ACADIA Pharmaceuticals Inc. (ACAD)|XENE: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity VKTX|Supernus Corp (SUPN) - Current Liabilities to Capital|Short-Term Debt to Capital CPRX|Short-Term Debt to Equity Ratio denalitherapeutics.com|Harmony Biosciences Holdings, Inc. - Short-Term Debt to Capital|Current Liabilities to Capital BHVN (Biohaven Ltd)|Short-Term Debt to Equity Amylyx|Ratio of Short-Term Indebtedness to Capital Trevi Corp TRVI|Short-Term Debt to Capital PRAX (Praxis Precision Medicines)|AVXL - Short-Term Debt to Capital Coefficient|Prothena Corp (PRTA) - Short-Term Debt to Capital|Alector (ALEC) - Short-Term Debt to Equity|Short-Term Debt to Capital ANNX (Annexon Inc.)|Current Liabilities to Capital OMER|Short-Term Debt to Equity Neurogene Inc. (NGNE)|Short-Term Debt to Equity ACIU (acimmune.com)|Short-Term Debt to Equity Voyager Therapeutics, Inc. VYGR|NMRA - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Scilex Holding Co. (SCLX)|TVGN - Ratio of Short-Term Indebtedness to Capital|alphacognition.com - Short-Term Debt to Capital|CGTX (cogrx.com) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Inhibikase Therapeutics, Inc. (IKT)|Short-Term Debt to Capital Ratio Cassava Sciences Inc|Short-Term Debt to Capital ASRT (Assertio Holdings, Inc.)|Short-Term Debt to Equity Ratio coyatherapeutics.com COYA|Short-Term Debt to Equity Ratio VTGN|Short-Term Debt to Capital Coefficient Ovid Therapeutics Inc OVID|ABOS: Short-Term Debt to Capital|CRVO - Short-Term Debt to Equity Ratio|alteritytherapeutics.com (ATHE) - Short-Term Debt to Capital|CLNN (Clene) - Short-Term Debt to Equity|Short-Term Debt to Equity PepGen Inc|Short-Term Debt to Equity JUNS|Short-Term Debt to Equity Relmada Therapeutics, Inc. (RLMD)|Short-Term Debt to Equity ANVS (Annovis Bio Inc)|GRCE - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio Firefly Neuro AIFF|KLTO (ANEW Medical, Inc.) - Short-Term Debt to Capital|NeuroSense Therapeutics (NRSN) - Current Liabilities to Capital|RVPH: Short-Term Debt to Equity Ratio|MTVA (MetaVia) - Short-Term Debt to Capital|NRXS - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital HSDT|Passage Bio, Inc. - Short-Term Debt to Equity|Current Liabilities to Capital bionomics.com.au (NEUP)|Minerva Neurosciences, Inc. - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Athira Pharma Inc ATHA|ADXN (Addex Therapeutics, Ltd.) - Short-Term Debt to Capital|ALZN: Current Liabilities to Capital|Short-Term Debt to Equity cyclerion.com CYCN|Protagenic Therapeutics, Inc. (PTIX) - Ratio of Short-Term Indebtedness to Capital|KTTA: Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Cortigent Medical|Short-Term Debt to Capital Avenue Therapeutics, Inc (ATXI)|Short-Term Debt to Equity BrainStorm Cell Therapeutics Inc. (BCLI)|CARA: Short-Term Debt to Capital|chromocell.com - Current Liabilities to Capital|ELYM - Short-Term Debt to Equity|ITCI: Short-Term Debt to Equity|Longboard Pharma (LBPH) - Short-Term Debt to Equity|Short-Term Debt to Equity Marinus Pharma|NKGN - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital neurobopharma.com|SAGE (Sage Therapeutics) - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient SNPX (Synaptogenix Inc.)|TRVN - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio Vigil Neuroscience Inc. VIGL|WENA: Short-Term Debt to Capital|cerevel.com (CERE) - Short-Term Debt to Equity Ratio